Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against schistosoma haematobium: Randomized, exploratory open-label trial

Clinical Infectious Diseases

Volumn 50, Issue 9, 2010, Pages 1205-1213

  Keiser, Jennifer ^a   N'Guessan, Nicaise A ^b   Adoubryn, Koffi D ^c   Silué, Kigbafori D ^b,d   Vounatsou, Penelope ^a   Hatz, Christoph ^a   Utzinger, Jürg ^a   N'Goran, Eliézer K ^b,d  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b Laboratoire de Zoologie et Biologie Animale   (Spain)

^c UFR des Sciences Médicales   (Spain)

^d Centre Suisse de Recherches Scientifiques   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARINATE; ARTESUNATE; ARTESUNATE PLUS MEFLOQUINE; MEFLOQUINE; PRAZIQUANTEL; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ARTICLE; CHILD; CHILL; CLEARANCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COUGHING; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; EGG; FEMALE; HEADACHE; HELMINTH; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALARIA; MALE; MENTAL DISEASE; MIXED INFECTION; MORBIDITY; NEUROLOGIC DISEASE; NONHUMAN; OPEN STUDY; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTOZOAL INFECTION; PROTOZOON; RANDOMIZED CONTROLLED TRIAL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS HAEMATOBIA; SCHOOL CHILD; SINGLE DRUG DOSE; SOIL; THERAPY EFFECT; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VERTIGO;

ABDOMINAL PAIN; ANIMALS; ANTHELMINTICS; ARTEMISININS; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INCIDENCE; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; PARASITE EGG COUNT; PLASMODIUM FALCIPARUM; PRAZIQUANTEL; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; TREATMENT OUTCOME;

EID: 77950974016     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/651682     Document Type: Article

References (35)

1. Davis A. Schistosomiasis. In: Cook GC, Zumla AI, eds. Manson's Tropical Diseases, 22nd edition. London: Saunders, 2009:1413-1456.
2. Gryseels B, Folman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet 2006; 368:1106-1118.
3. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006;6:411-425. (Pubitemid 43949139)
4. Utzinger J, Raso G, Brooker S, et al. Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitology 2009; 136:1859-1874.
5. Doenhoff MJ, Cioli D, Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 2008;21:659-667.
6. Melman SD, Steinauer ML, Cunningham C, et al. Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl Trop Dis 2009;3:e504.
7. Oliveira MF, d'Avila JC, Torres CR, et al. Haemozoin in Schistosoma mansoni. Mol Biochem Parasitai 2000;111:217-221.
8. Kumar S, Guha M, Choubey V, Maity P, Bandyopadhyay U. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update. Life Sci 2007;80:813-828. (Pubitemid 46149853)
9. Keiser J, Chollet J, Xiao SH, et al. Mefloquine-an aminoalcohol with promising antischistosomal properties in mice. PLoS Negl Trop Dis 2009;3:e350.
10. Manneck T, Haggenmüller Y, Keiser J. Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni Parasitology 2010; 137:85-98.
11. Utzinger J, Xiao SH, Tanner M, Keiser J. Artemisinins for schistosomiasis and beyond. Curr Opin Investig Drugs 2007;8:105-116.
12. Keiser J, Utzinger J. Artemisinins and synthetic trioxolanes in the treatment of helminth infections. Curr Opin Infect Dis 2007;20:605-612. (Pubitemid 350059520)
13. Sissoko MS, Dabo A, Traore H, et al. Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children. PLoS One 2009;4:e6732.
14. World Health Organization. Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva, Switzerland: World Health Organization, 2006.
15. Adoubryn KD, Ouhon J, Yapo CG, Assoumou EY, Ago KML, Assoumou A. Profil épidémiologique des schistosomoses chez les enfants d'âge scolaire dans la région de l'Agnéby (sud-est de la Côte-d'Ivoire). Bull Soc Pathol Exot 2006;99:28-31. (Pubitemid 43410024)
16. Julious S. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat 2005;4:287-291. (Pubitemid 43013602)
17. Castro N, Medina R, Sotelo J, Jung H. Bioavailability of praziquantel increases with concomitant, administration of food. Antimicrob Agents Chemother 2000;44:2903-2904.
18. Plouvier S, Leroy J-C, Colette J. A propos d'une technique simple de filtration des urines dans le diagnostic de la bilharziose urinaire en enquête de masse. Med Trop (Mars) 1975;35:229-230.
19. Katz N, Chaves A, Pellegrino J. A. simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972; 14:397-1100
20. Utzinger J, Botero-Kleiven S, Castelli F, et al. Microscopic diagnosis of sodium acetate-acetic acid-formalin-fixed stool samples for helminths and intestinal protozoa: a comparison among European reference laboratories. Clin Microbiol Infect 2010; 16:267-273.
21. World Health Organization (WHO). Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. WHO Tech Rep Ser 2002;912:i-iv, 1-57.
22. White NJ, Nosten F, Looareesuwan S, et al. Averting a malaria disaster. Lancet. 1999;353:1965-1967.
23. Olliaro P, Wells TN. The global portfolio of new antimalarial medicines under development. Clin Pharmacol Ther 2009;85:584-595.
24. N'Goran EK, Utzinger J, Gnaka HN, et al. Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections. Am J Trop Med Hyg 2003; 68: 24-32.
25. de Vlas SJ, Gryseels B. Underestimation of Schistosoma mansoni prevalences. Parasitai Today 1992;8:274-277.
26. Utzinger J, N'Goran EK, N'Dri A, Lengeler C, Xiao SH, Tanner M. Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet 2000;355:1320-1325.
27. Bergquist R, Johansen MV, Utzinger J. Diagnostic dilemmas in helminthology: what tools to use and when? Trends Parasitai 2009; 25: 151-156.
28. Boulanger D, Dieng Y, Cisse B, et al. Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks. Trans R Soc Trop Med Hyg 2007; 101:113-116. (Pubitemid 44848173)
29. Borrmann S, Szlezák N, Faucher J-F, et al. Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a doubleblind, randomized, placebo-controlled study. J Infect Dis 2001; 184: 1363-1366.
30. Inyang-Etoh PC, Ejezie GC, Useh MF, Inyang-Etoh EC. Efficacy of artesunate in the treatment of urinary schistosomiasis in an endemic community in Nigeria. Ann Trop Med Parasitai 2004;98:491-499.
31. De Clercq D, Vercruysse J, Kongs A, Verlé P, Dompnier JP, Faye PC. Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren. Acta Trop 2002;82:61-66.
32. Karbwang J, White NJ. Clinical pharmacokinetics of mefloquine. Clin Pharmacokinet 1990; 19:264-279.
33. Chen LH, Wilson ME, Schlagenhauf P. Controversies and misconceptions in malaria chemoprophylaxis for travelers. JAMA 2007; 297: 2251-2263. (Pubitemid 47010883)
34. N'Goran EK, Gnaka HN, Tanner M, Utzinger J. Efficacy and sideeffects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire. Ann Trop Med Parasitai 2003;97:37-51.
35. Danso-Appiah A, Utzinger J, Liu J, Olliaro P. Drugs for treating urinary schistosomiasis. Cochrane Database Syst Rev 2008:CD000053.